Jean‐Jacques Godfroid

901 total citations
33 papers, 797 citations indexed

About

Jean‐Jacques Godfroid is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Jean‐Jacques Godfroid has authored 33 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Jean‐Jacques Godfroid's work include Receptor Mechanisms and Signaling (5 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Jean‐Jacques Godfroid is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Jean‐Jacques Godfroid collaborates with scholars based in France, Belgium and United Kingdom. Jean‐Jacques Godfroid's co-authors include Françoise Heymans, Jacques Benveniste, Élie Michel, Eliane Coëffier, Catherine Redeuilh, Martine Tencé, Dominique Manéchez, Béatrice Guardiola‐Lemaître, Georges Dive and Judith Polonsky and has published in prestigious journals such as Biochemical Journal, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Jean‐Jacques Godfroid

33 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Jacques Godfroid France 15 323 298 97 83 69 33 797
Atul Khandwala United States 17 261 0.8× 243 0.8× 97 1.0× 94 1.1× 67 1.0× 47 892
Françoise Heymans France 19 467 1.4× 219 0.7× 194 2.0× 156 1.9× 87 1.3× 54 1.0k
Kenji Akahane Japan 10 244 0.8× 181 0.6× 68 0.7× 59 0.7× 53 0.8× 24 555
J. J. Godfroid France 12 192 0.6× 221 0.7× 86 0.9× 68 0.8× 51 0.7× 24 488
Wolfgang Albrecht Germany 19 522 1.6× 396 1.3× 187 1.9× 56 0.7× 65 0.9× 69 1.2k
Hans Hilpert Switzerland 18 426 1.3× 356 1.2× 157 1.6× 179 2.2× 41 0.6× 36 1.1k
Ivan L. Pinto United Kingdom 20 507 1.6× 489 1.6× 106 1.1× 116 1.4× 78 1.1× 37 1.1k
Richard Sulsky United States 12 640 2.0× 203 0.7× 135 1.4× 165 2.0× 69 1.0× 18 1.1k
Claudio F. Sturino Canada 18 355 1.1× 644 2.2× 166 1.7× 69 0.8× 43 0.6× 29 1.1k
Yasuteru Iijima Japan 19 465 1.4× 328 1.1× 243 2.5× 138 1.7× 43 0.6× 39 994

Countries citing papers authored by Jean‐Jacques Godfroid

Since Specialization
Citations

This map shows the geographic impact of Jean‐Jacques Godfroid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Jacques Godfroid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Jacques Godfroid more than expected).

Fields of papers citing papers by Jean‐Jacques Godfroid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Jacques Godfroid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Jacques Godfroid. The network helps show where Jean‐Jacques Godfroid may publish in the future.

Co-authorship network of co-authors of Jean‐Jacques Godfroid

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Jacques Godfroid. A scholar is included among the top collaborators of Jean‐Jacques Godfroid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Jacques Godfroid. Jean‐Jacques Godfroid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Chang‐Zhi, Mohamed Touaibia, Catherine Redeuilh, et al.. (2005). Inhibition of secretory phospholipase A2. 2-Synthesis and structure–activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme. Bioorganic & Medicinal Chemistry. 13(6). 1989–2007. 25 indexed citations
2.
Dong, Chang‐Zhi, Anthony Romieu, Carine M. Mounier, et al.. (2002). Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2. Biochemical Journal. 365(2). 505–511. 11 indexed citations
3.
Serradji, Nawal, Marc Martín, Nathalie Dereuddre‐Bosquet, et al.. (2000). Structure−Activity Relationships in Platelet-Activating Factor (PAF). 10. From PAF Antagonism to Inhibition of HIV-1 Replication. Journal of Medicinal Chemistry. 43(11). 2149–2154. 27 indexed citations
6.
Rodrı́guez, Ana R., Miguel Nomen, Bernd W. Spur, & Jean‐Jacques Godfroid. (1999). An Efficient Asymmetric Synthesis of Prostaglandin E1. European Journal of Organic Chemistry. 1999(10). 2655–2662. 34 indexed citations
7.
Virsolvy, Anne, Dominique Manéchez, Jean‐Jacques Godfroid, et al.. (1999). In vitro mechanism of action on insulin release of S‐22068, a new putative antidiabetic compound. British Journal of Pharmacology. 128(5). 1021–1026. 15 indexed citations
8.
Marc, Sylvie, Bruno Pfeiffer, Dominique Manéchez, et al.. (1998). Potent antihyperglycaemic property of a new imidazoline derivative S‐22068 (PMS 847) in a rat model of NIDDM. British Journal of Pharmacology. 124(8). 1591–1596. 23 indexed citations
11.
Virsolvy, Anne, Karine Peyrollier, Dominique Manéchez, et al.. (1997). Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S‐21663: evidence for the existence of a novel imidazoline site in β cells. British Journal of Pharmacology. 122(4). 786–791. 19 indexed citations
13.
Mounier, Carine M., et al.. (1996). 4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors. Biochemical Pharmacology. 51(6). 737–742. 43 indexed citations
15.
Heymans, Françoise, et al.. (1994). Design and modeling of new PAF antagonists - 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-substituted carbonyloxymethyl piperazines. Open Repository and Bibliography (University of Liège). 10. 2 indexed citations
16.
Lamouri, Aazdine, et al.. (1991). New hypothesis on the conformation of the PAF-receptor from studies on the geometry of selected platelet-activating factor-antagonists.. PubMed. 4(3). 343–6. 9 indexed citations
17.
Lamotte‐Brasseur, Josette, et al.. (1991). PAF-receptor. III. Conformational and electronic properties of PAF-like agonists and antagonists. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1085(1). 91–105. 9 indexed citations
18.
Godfroid, Jean‐Jacques, et al.. (1986). Synthesis of ether phospholipids. Pharmacological Research Communications. 18. 1–10. 3 indexed citations
19.
Godfroid, Jean‐Jacques, et al.. (1980). Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline. FEBS Letters. 116(2). 161–164. 102 indexed citations
20.
Convert, Odile, et al.. (1977). Etude en RMN du carbone 13 de dicoumarols substitués. Organic Magnetic Resonance. 10(1). 220–223. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026